CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-21 | Sanders Corazon (Corsee) D. Director | Grant or award | +10,985 | 57,226 | ||
| 2025-05-21 | Sanders Corazon (Corsee) D. Director | Grant or award · Share Option (Right to Buy) | +22,750 | 22,750 | ||
| 2025-05-21 | HOOPER ANTHONY C Director | Grant or award | +10,985 | 64,740 | ||
| 2025-05-21 | HOOPER ANTHONY C Director | Grant or award · Share Option (Right to Buy) | +22,750 | 22,750 | ||
| 2025-05-21 | BAKER BROS. ADVISORS LP Director | Grant or award | +21,970 | 148,065 | ||
| 2025-05-21 | BAKER BROS. ADVISORS LP Director | Grant or award | +21,970 | 148,069 | ||
| 2025-05-21 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +45,500 | 45,500 | ||
| 2025-05-21 | BAKER BROS. ADVISORS LP Director | Grant or award · Share Option (Right to Buy) | +45,500 | 45,500 | ||
| 2025-05-13 | Wang Xiaodong Director | Option exercise 10b5-1 | +41,760 | $6.50 | $271K | 41,760 |
| 2025-05-13 | Wang Xiaodong Director | Sale 10b5-1 | −10,221 | $222.83 | $2.3M | 31,539 |
| 2025-05-13 | Wang Xiaodong Director | Sale 10b5-1 | −21,235 | $223.41 | $4.7M | 10,304 |
| 2025-05-13 | Wang Xiaodong Director | Sale 10b5-1 | −10,104 | $224.32 | $2.3M | 200 |
| 2025-05-13 | Wang Xiaodong Director | Sale 10b5-1 | −200 | $225.68 | $45K | 0 |
| 2025-05-13 | Wang Xiaodong Director | Option exercise · Share Option (Right to Buy) 10b5-1 | −542,880 | 542,887 | ||
| 2025-05-09 | OYLER JOHN Chief Executive Officer | Option exercise | +4,055,415 | $0.50 | $2.0M | 10,154,040 |
| 2025-05-09 | OYLER JOHN Chief Executive Officer | Shares withheld for taxes | −1,990,603 | $17.85 | $35.5M | 8,163,437 |
| 2025-05-09 | OYLER JOHN Chief Executive Officer | Option exercise · Share Option (Right to Buy) | −4,055,415 | 7 | ||
| 2025-04-14 | Wang Xiaodong Director | Option exercise 10b5-1 | +41,760 | $6.50 | $271K | 41,760 |
| 2025-04-14 | Wang Xiaodong Director | Sale 10b5-1 | −995 | $237.56 | $236K | 40,765 |
| 2025-04-14 | Wang Xiaodong Director | Sale 10b5-1 | −805 | $238.48 | $192K | 39,960 |
Page 26 of 71 · 1,406 trades